Sens. Shaheen and Collins, Reps. DeGette and Bilirakis Warn Administration Against Proposal That Could Harm Diabetic Patients’ Access to Glucose Monitors, Insulin Pumps

The lawmakers wrote, "As you know, diabetes is one of the most common and costliest chronic diseases among Americans. Despite the prevalence and costly nature of this disease, many Medicare beneficiaries have difficulty accessing effective tools to manage their diabetes, such as CGMs and insulin pumps, [...]. These tools are also cost-effective, as research has shown that their use has yielded billions of dollars of savings to federal health care programs, namely due to reduced hospitalization and utilization of emergency department visits. Federal policies should support access to these technologies."